{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:01:16Z","timestamp":1776466876708,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86035-6","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:12:37Z","timestamp":1737396757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Synthesis and evaluation of nitrochromene derivatives as potential antileishmanial therapeutics through biological and computational studies"],"prefix":"10.1038","volume":"15","author":[{"given":"Niloofar","family":"Javid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Asadipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Salarkia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Langarizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bagher","family":"Amirheidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Iraji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojjat","family":"Rezaiezadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Hassanpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaghoub","family":"Pourshojaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"8","key":"86035_CR1","first-page":"e525","volume":"15","author":"TS Tiuman","year":"2011","unstructured":"Tiuman, T. S., Santos, A. O., Ueda-Nakamura, T., Dias Filho, B. P. & Nakamura, C. V. J. I. J. I. D. Recent advances in leishmaniasis treatment. J. Infect. Dis. 15 (8), e525\u2013e532 (2011).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"86035_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/ced.14919","volume":"47","author":"S Pradhan","year":"2022","unstructured":"Pradhan, S., Schwartz, R., Patil, A., Grabbe, S. & Goldust, M. J. C. Dermatology e: treatment options for leishmaniasis. Clin. Exp. Dermatol. 47 (3), 516\u2013521 (2022).","journal-title":"Clin. Exp. Dermatol."},{"key":"86035_CR3","doi-asserted-by":"publisher","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","volume":"104","author":"BM Roatt","year":"2020","unstructured":"Roatt, B. M. et al. Biotechnology: recent advances and new strategies on leishmaniasis treatment. Appl. Microbiol. Biotechnol. 104, 8965\u20138977 (2020).","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"12","key":"86035_CR4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0020-7519(01)00259-4","volume":"31","author":"RJ Burchmore","year":"2001","unstructured":"Burchmore, R. J., Barrett & MPJIjfp Life in vacuoles\u2013nutrient acquisition by Leishmania amastigotes. Int. J. Parasitol. 31 (12), 1311\u20131320 (2001).","journal-title":"Int. J. Parasitol."},{"issue":"9","key":"86035_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pt.2006.06.012","volume":"22","author":"Kamhawi SJTip","year":"2006","unstructured":"Kamhawi SJTip. Phlebotomine sand flies and Leishmania parasites: friends or foes? Trends Parasitol. 22 (9), 439\u2013445 (2006).","journal-title":"Trends Parasitol."},{"issue":"2","key":"86035_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/1735-5362.223793","volume":"13","author":"V Sheikhmoradi","year":"2018","unstructured":"Sheikhmoradi, V., Saberi, S., Saghaei, L., Pestehchian, N. & Fassihi, A. J. R. Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands. Res. Pharm. Sci. 13 (2), 111\u2013120 (2018).","journal-title":"Res. Pharm. Sci."},{"issue":"10174","key":"86035_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S0140-6736(18)33057-5","volume":"393","author":"S Burza","year":"2019","unstructured":"Burza, S., Croft, S. L. & Boelaert, M. J. T. Leishmaniasis\u2013authors\u2019 reply. Lancet 393 (10174), 872\u2013873 (2019).","journal-title":"Lancet"},{"issue":"6","key":"86035_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4103\/1735-5362.327508","volume":"16","author":"V Rahnama","year":"2021","unstructured":"Rahnama, V. et al. Artemether-loaded nanostructured lipid carriers: preparation, characterization, and evaluation of: in vitro: effect on: Leishmania major. Res. Pharm. Sci. 16 (6), 623\u2013633 (2021).","journal-title":"Res. Pharm. Sci."},{"issue":"9","key":"86035_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger, R., Dujardin, J-C., Louzir, H., Pirmez, C. & Alexander, B. Brooker SJTLid: cutaneous leishmaniasis. Lancet. Infect. Dis. 7 (9), 581\u2013596 (2007).","journal-title":"Lancet. Infect. Dis"},{"issue":"7","key":"86035_CR10","first-page":"601","volume":"112","author":"I Abad\u00edas-Granado","year":"2021","unstructured":"Abad\u00edas-Granado, I., Diago, A., Cerro, P., Palma-Ruiz, A. & Gilaberte, Y. J. A. D. S. Cutaneous and mucocutaneous leishmaniasis. Actas Dermo-Sifiliogr\u00e1ficas (Engl. Ed.) 112 (7), 601\u2013618 (2021).","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (Engl. Ed.)"},{"issue":"1","key":"86035_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/pharmacy12010030","volume":"12","author":"M Shmueli","year":"2024","unstructured":"Shmueli, M. & Ben-Shimol, S. J. P. Review of Leishmaniasis treatment: can we see the forest through the trees? Pharmacy 12 (1), 30 (2024).","journal-title":"Pharmacy"},{"issue":"5","key":"86035_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0035-9203(00)90055-5","volume":"94","author":"M Boelaert","year":"2000","unstructured":"Boelaert, M., Criel, B., Leeuwenburg, J., Van Damme, W. & Le Ray, D. Stuyft PJTotRSoTM, Hygiene: visceral leishmaniasis control: a public health perspective. Trans. R. Soc. Trop. Med. Hyg. 94 (5), 465\u2013471 (2000).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"1","key":"86035_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/21678707.2024.2335248","volume":"12","author":"S Sundar","year":"2024","unstructured":"Sundar, S., Singh, J., Singh, V. K., Agrawal, N. & Kumar, R. J. E. O. O. D. Current and emerging therapies for the treatment of leishmaniasis. Expert Opin. Orphan Drugs. 12 (1), 19\u201332 (2024).","journal-title":"Expert Opin. Orphan Drugs"},{"issue":"5","key":"86035_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"Desjeux","year":"2004","unstructured":"Desjeux & PJCi Microbiology, diseases i: Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27 (5), 305\u2013318 (2004).","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"5","key":"86035_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2230.2000.00664.x","volume":"25","author":"NJC Hepburn","year":"2000","unstructured":"Hepburn, N. J. C. Dermatology e: cutaneous leishmaniasis. Clin. Exp. Dermatol. 25 (5), 363\u2013370 (2000).","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"86035_CR16","first-page":"617521","volume":"2010","author":"HCJBRI Maltezou","year":"2010","unstructured":"Maltezou, H. C. J. B. R. I. Drug resistance in visceral leishmaniasis. Biomed. Res. Int. 2010 (1), 617521 (2010).","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"86035_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/1735-5362.189314","volume":"11","author":"SE Sajjadi","year":"2016","unstructured":"Sajjadi, S. E. et al. Mohseni NJRips: antileishmanial activity of prenylated coumarins isolated from Ferulago Angulata and Prangos asperula. Res. Pharm. Sci. 11 (4), 324\u2013331 (2016).","journal-title":"Res. Pharm. Sci."},{"issue":"5","key":"86035_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1590\/S0074-02762007000500001","volume":"102","author":"JJMIOC Shaw","year":"2007","unstructured":"Shaw, J. J. M. I. O. C. The leishmaniases-survival and expansion in a changing world: a mini-review. Mem\u00f3rias do Instituto Oswaldo Cruz. 102 (5), 541\u2013547 (2007).","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"86035_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jtemb.2019.08.003","volume":"56","author":"P Tavakoli","year":"2019","unstructured":"Tavakoli, P., Ghaffarifar, F., Delavari, H., Shahpari & NJJoTEiM Biology: efficacy of manganese oxide (Mn2O3) nanoparticles against Leishmania major in vitro and in vivo. Ournal Trace Elem. Med. Biol. 56, 162\u2013168 (2019).","journal-title":"Ournal Trace Elem. Med. Biol."},{"issue":"11","key":"86035_CR20","doi-asserted-by":"publisher","first-page":"e00583","DOI":"10.1128\/aac.00583-22","volume":"66","author":"L Navidpour","year":"2022","unstructured":"Navidpour, L. et al. Antileishmanial activities of (Z)-2-(nitroimidazolylmethylene)-3 (2H)-benzofuranones: synthesis, in vitro assessment, and bioactivation by NTR 1 and 2. Antimicrob. Agents Chemother. 66 (11), e00583\u2013e00522 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"86035_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","volume":"103","author":"DO Santos","year":"2008","unstructured":"Santos, D. O. et al. Pinho RTJPr: leishmaniasis treatment\u2014a challenge that remains: a review. Parasitol. Res. 103, 1\u201310 (2008).","journal-title":"Parasitol. Res."},{"issue":"6","key":"86035_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ijantimicag.2007.01.004","volume":"29","author":"S Natera","year":"2007","unstructured":"Natera, S., Machuca, C., Padr\u00f3n-Nieves, M., Romero, A. & D\u00edaz, E. Ponte-Sucre AJIjoaa: Leishmania spp.: proficiency of drug-resistant parasites. Int. J. Antimicrob. Agents 29 (6), 637\u2013642 (2007).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"11","key":"86035_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","volume":"21","author":"SL Croft","year":"2005","unstructured":"Croft, S. L., Barrett, M. P., Urbina & JAJTip Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol. 21 (11), 508\u2013512 (2005).","journal-title":"Trends Parasitol."},{"issue":"4","key":"86035_CR24","first-page":"475","volume":"51","author":"M Abreshteh","year":"2019","unstructured":"Abreshteh, M., Khandan-Barani, K. & Hassanabadi, A. J. B. C. C. Aspartic acid as an efficient and green catalyst for the one-pot synthesis of 2-amino-4H-chromene derivatives under thermal, solvent free conditions. Bulg. Chem. Commun. 51 (4), 475\u2013478 (2019).","journal-title":"Bulg. Chem. Commun."},{"key":"86035_CR25","doi-asserted-by":"publisher","first-page":"133012","DOI":"10.1016\/j.molstruc.2022.133012","volume":"1263","author":"MK Katiyar","year":"2022","unstructured":"Katiyar, M. K. et al. Synthetic strategies and pharmacological activities of chromene and its derivatives: an overview. J. Mol. Struct. 1263, 133012 (2022).","journal-title":"J. Mol. Struct."},{"issue":"41","key":"86035_CR26","doi-asserted-by":"publisher","first-page":"9939","DOI":"10.1021\/ja002033k","volume":"122","author":"K Nicolaou","year":"2000","unstructured":"Nicolaou, K. et al. Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans. J. Am. Chem. Soc. 122 (41), 9939\u20139953 (2000).","journal-title":"J. Am. Chem. Soc."},{"key":"86035_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10904-019-01295-w","volume":"30","author":"A Abd-El-Aziz","year":"2020","unstructured":"Abd-El-Aziz, A. et al. First example of cationic cyclopentadienyliron based chromene complexes and polymers: synthesis, characterization, and biological applications. J. Inorg. Organomet. Polym Mater. 30, 131\u2013146 (2020).","journal-title":"J. Inorg. Organomet. Polym Mater."},{"key":"86035_CR28","first-page":"131","volume":"3","author":"A Pourkazemi","year":"2020","unstructured":"Pourkazemi, A. et al. Efficient production of 2-amino-4H-chromenes and 14-aryl-14H-dibenzo [a, j] xanthenes catalyzed by N, N-diethyl-N-sulfoethanaminium hydrogen sulfate. Asian J. Nanosci. Mater. 3, 131\u2013137 (2020).","journal-title":"Asian J. Nanosci. Mater."},{"issue":"1","key":"86035_CR29","first-page":"57","volume":"10","author":"E Jahangard","year":"2020","unstructured":"Jahangard, E., Khazdooz, L. & Zarei, A. J. I. J. C. Synthesis and in vitro antibacterial study of dihydropyrano [3, 2-c] chromene derivatives by nano fluoro apatite doped with mg and Si as a cooperative catalyst. Iran. J. Catal. 10 (1), 57\u201363 (2020).","journal-title":"Iran. J. Catal."},{"issue":"1","key":"86035_CR30","first-page":"13","volume":"54","author":"FA Eid","year":"2004","unstructured":"Eid, F. A., Abd El-Wahab, A. H. & EL-HAG ALI GA, Khafagy, M. M. J. A. Synthesis and antimicrobial evaluation of naphtho [2, 1-b] pyrano [2, 3-d] pyrimidine and pyrano [3, 2-e][1, 2, 4] triazolo [1, 5-c] pyrimidine derivatives. Acta Pharm. 54 (1), 13\u201326 (2004).","journal-title":"Acta Pharm."},{"issue":"17","key":"86035_CR31","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.2174\/1385272822666180530104302","volume":"22","author":"M Mamaghani","year":"2018","unstructured":"Mamaghani, M., Nia, R. H., Tavakoli, F. & Jahanshahi, P. J. C. O. C. Recent advances in the MCRs synthesis of chromenes: a review. Curr. Org. Chem. 22 (17), 1704\u20131769 (2018).","journal-title":"Curr. Org. Chem."},{"issue":"S2","key":"86035_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1634\/theoncologist.6-suppl_2-29","volume":"6","author":"DM Rust","year":"2001","unstructured":"Rust, D. M. & Soignet, S. L. J. T. O. Risk\/benefit profile of arsenic trioxide. Oncologist 6 (S2), 29\u201332 (2001).","journal-title":"Oncologist"},{"issue":"20","key":"86035_CR33","doi-asserted-by":"publisher","first-page":"10476","DOI":"10.1021\/cr500075s","volume":"114","author":"R Pratap","year":"2014","unstructured":"Pratap, R. & Ram, V. J. J. C. Natural and synthetic chromenes, fused chromenes, and versatility of dihydrobenzo [h] chromenes in organic synthesis. Chem. Rev. 114 (20), 10476\u201310526 (2014).","journal-title":"Chem. Rev."},{"key":"86035_CR34","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3389\/fmicb.2016.01379","volume":"7","author":"S Shafi","year":"2016","unstructured":"Shafi, S. et al. Zaman MSJFiM: \u03b2-Nitrostyrenes as potential anti-leishmanial agents. Front. Microbiol. 7, 1379 (2016).","journal-title":"Front. Microbiol."},{"key":"86035_CR35","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ejmech.2014.09.017","volume":"86","author":"S Rahmani-Nezhad","year":"2014","unstructured":"Rahmani-Nezhad, S. et al. Shafiee AJEjomc: synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents. Eur. J. Med. Chem. 86, 562\u2013569 (2014).","journal-title":"Eur. J. Med. Chem."},{"key":"86035_CR36","first-page":"893","volume":"30","author":"SC Carmo LFd, Silva","year":"2019","unstructured":"Carmo LFd, Silva, S. C. et al. The role of L-Proline and co-catalysts in the enantioselectivity of OXA-Michael-Henry reactions. J. Braz. Chem. Soc. 30, 893\u2013903 (2019).","journal-title":"J. Braz. Chem. Soc."},{"issue":"17","key":"86035_CR37","first-page":"4827","volume":"48","author":"DA Scudiero","year":"1988","unstructured":"Scudiero, D. A. et al. Boyd MRJCr: evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48 (17), 4827\u20134833 (1988).","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"86035_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"TJJ Mosmann","year":"1983","unstructured":"Mosmann & TJJoim Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65 (1\u20132), 55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"86035_CR39","unstructured":"Asadipour, A. et al. Targeting Leishmaniasis with nitrovinyl derivatives: their synthesis, in vitro assessment, and computational exploration. Curr. Med. Chem."},{"issue":"11","key":"86035_CR40","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1080\/07391102.2020.1863263","volume":"40","author":"M \u00d6zdemir","year":"2022","unstructured":"\u00d6zdemir, M. et al. Yal\u00e7\u0131n BJJoBS, Dynamics: design and in silico study of the novel coumarin derivatives against SARS-CoV-2 main enzymes. J. Biomol. Struct. Dyn. 40 (11), 4905\u20134920 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"D1","key":"86035_CR41","doi-asserted-by":"publisher","first-page":"D475","DOI":"10.1093\/nar\/gks1200","volume":"41","author":"PW Rose","year":"2012","unstructured":"Rose, P. W. et al. Nar: the RCSB Protein Data Bank: new resources for research and education. Nucleic Acids Res. 41 (D1), D475\u2013D482 (2012).","journal-title":"Nucleic Acids Res."},{"issue":"47","key":"86035_CR42","doi-asserted-by":"publisher","first-page":"e202303228","DOI":"10.1002\/slct.202303228","volume":"8","author":"E Faghih-Mirzaei","year":"2023","unstructured":"Faghih-Mirzaei, E. et al. Unraveling the anticancer potential of cinnamonitrile derivatives: in vitro evaluation and molecular docking. ChemistrySelect 8 (47), e202303228 (2023).","journal-title":"ChemistrySelect"},{"issue":"4","key":"86035_CR43","first-page":"918","volume":"68","author":"MA Langarizadeh","year":"2021","unstructured":"Langarizadeh, M. A. et al. Phlorotannins as HIV Vpu inhibitors, an in silico virtual screening study of marine natural products. Biotechnol. Appl. Chem. 68 (4), 918\u2013926 (2021).","journal-title":"Biotechnol. Appl. Chem."},{"issue":"4","key":"86035_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4103\/1735-5362.293515","volume":"15","author":"M Zahedi","year":"2020","unstructured":"Zahedi, M. et al. Anti-toxoplasma gondii activity of 5-oxo-hexahydroquinoline derivatives: synthesis: in vitro: and: in vivo: evaluations, and molecular docking analysis. Res. Pharm. Sci. 15 (4), 367\u2013380 (2020).","journal-title":"Res. Pharm. Sci."},{"key":"86035_CR45","doi-asserted-by":"publisher","first-page":"132569","DOI":"10.1016\/j.molstruc.2022.132569","volume":"1258","author":"MA Langarizadeh","year":"2022","unstructured":"Langarizadeh, M. A. et al. A novel dual three and five-component reactions between dimedone, aryl aldehydes, and 1-naphthylamine: synthesis and computational studies. J. Mol. Struct. 1258, 132569 (2022).","journal-title":"J. Mol. Struct."},{"issue":"3","key":"86035_CR46","first-page":"396","volume":"8","author":"TR Riabi","year":"2013","unstructured":"Riabi, T. R., Sharifi, I., Mohammadi, A. M., Khamesipour, A. & Parizi, M. H. J. I. J. P. Evaluation of a possible synergistic effect of meglumine antimoniate with paromomycin, miltefosine or allopurinol on in vitro susceptibility of Leishmania Tropica resistant isolate. Iran. J. Parasitol. 8 (3), 396 (2013).","journal-title":"Iran. J. Parasitol."},{"issue":"3","key":"86035_CR47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.apsb.2020.08.011","volume":"11","author":"Q Sun","year":"2021","unstructured":"Sun, Q., Huang, M. & Wei, Y. Diversity of the reaction mechanisms of SAM-dependent enzymes. Acta Pharm. Sin. B 11 (3), 632\u2013650 (2021).","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"86035_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/mmi.14139","volume":"111","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee, S. et al. Sterol methyltransferase is required for optimal mitochondrial function and virulence in Leishmania major. Mol. Microbiol. 111 (1), 65\u201381 (2019).","journal-title":"Mol. Microbiol."},{"issue":"49","key":"86035_CR49","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.1021\/acs.biochem.5b00569","volume":"54","author":"JB Fields","year":"2015","unstructured":"Fields, J. B. et al. Bind and crawl association mechanism of Leishmania major peroxidase and cytochrome c revealed by Brownian and molecular dynamics simulations. Biochemistry 54 (49), 7272\u20137282 (2015).","journal-title":"Biochemistry"},{"key":"86035_CR50","doi-asserted-by":"crossref","unstructured":"Jasion, V. S., Doukov, T., Pineda, S. H., Li, H. & Poulos, T. L. Crystal structure of the Leishmania major peroxidase\u2013cytochrome c complex. Proc. Natil. Acad. Sci. 109(45), 18390\u201318394 (2012).","DOI":"10.1073\/pnas.1213295109"},{"issue":"03","key":"86035_CR51","first-page":"407","volume":"48","author":"S-X Liu","year":"2016","unstructured":"Liu, S-X., Jia, C-M., Yao, B-Y., Chen, X-L. & Zhang, Q. J. S. Cascade Oxa-Michael\u2013Henry Reaction of Salicylaldehydes with nitrostyrenes via Ball Milling: a solvent-free synthesis of 3-Nitro-2H-chromenes. Synthesis 48 (03), 407\u2013412 (2016).","journal-title":"Synthesis"},{"issue":"22","key":"86035_CR52","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1055\/s-0034-1378821","volume":"47","author":"GK Pathe","year":"2015","unstructured":"Pathe, G. K. & Ahmed, N. J. S. Mild and efficient reductive deoxygenation of epoxides to olefins with tin (II) chloride\/sodium iodide as a novel reagent. Synthesis 47 (22), 3542\u20133552 (2015).","journal-title":"Synthesis"},{"key":"86035_CR53","unstructured":"Shen, T-S-C., Ueng, C-H. & Yao, C-F. The Synthesis of 2, 2-disubstituted 3-nitrochromenes from Salicylaldehyde and 2, 2-disubstituted 1-nitroalkenes (Heterocycles, 2002)."},{"issue":"7","key":"86035_CR54","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1021\/acs.joc.9b03366","volume":"85","author":"R Mohanta","year":"2020","unstructured":"Mohanta, R. & Bez, G. J. T. J. O. C. Augmentation of enantioselectivity by spatial tuning of aminocatalyst: synthesis of 2-alkyl\/aryl-3-nitro-2 H-chromenes by tandem oxa-michael\u2013henry reaction. J. Org. Chem. 85 (7), 4627\u20134636 (2020).","journal-title":"J. Org. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86035-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86035-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86035-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:12:41Z","timestamp":1737396761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86035-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86035"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86035-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2571"}}